ARCHIVES

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

Bethesda System Revised For Reporting Pap Test Results

April 26, 2002

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974

NCI-Approved Clinical Trials

June 30, 2006

GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It

October 22, 1982